{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:04:44Z","timestamp":1783573484886,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ctro.2025.100965","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:57:26Z","timestamp":1745063846000},"page":"100965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives"],"prefix":"10.1016","volume":"53","author":[{"given":"Wiwatchai","family":"Sittiwong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pittaya","family":"Dankulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitchayut","family":"Wongsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tissana","family":"Prasartseree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajana","family":"Thaweerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerisa","family":"Thornsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongpop","family":"Tuntapakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctro.2025.100965_b0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.100965_b0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"Potter","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.100965_b0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijrobp.2019.03.038","article-title":"Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study","volume":"104","author":"Tan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100965_b0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.radonc.2022.07.009","article-title":"Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy","volume":"174","author":"Dankulchai","year":"2022","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.100965_b0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5114\/jcb.2020.100377","article-title":"Excess dose-related parameters (Vex, Rex, and iRex): novel predictors and late toxicity correlations in cervical cancer imageguided adaptive brachytherapy","volume":"12","author":"Prasartseree","year":"2020","journal-title":"J Contemp Brachytherapy"},{"issue":"5","key":"10.1016\/j.ctro.2025.100965_b0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(23)00147-X","article-title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial","volume":"24","author":"Mileshkin","year":"2023","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.ctro.2025.100965_b0035","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Duenas-Gonzalez","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2025.100965_b0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/OGX.0000000000001317","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-CX11\/gog-3047\/keynote-A18): A randomized, double-blind, phase 3 clinical trial","volume":"79","author":"Lorusso","year":"2024","journal-title":"Obstet Gynecol Surv"},{"issue":"10462","key":"10.1016\/j.ctro.2025.100965_b0045","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","article-title":"Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG interlace): An international, Multicentre, randomised phase 3 trial","volume":"404","author":"McCormack","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctro.2025.100965_b0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12885-021-08243-3","article-title":"Potential prognostic factors in progression-free survival for patients with cervical cancer","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2025.100965_b0060","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1038\/s41598-022-13616-0","article-title":"Development and validation of a prognostic prediction model including the minor lymphatic pathway for distant metastases in cervical cancer patients","volume":"12","author":"Thephamongkhol","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctro.2025.100965_b0065","article-title":"Nomogram models for the prognosis of cervical cancer: A SEER-based study","volume":"12","author":"Jiang","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.100965_b0070","article-title":"Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer","volume":"11","author":"Gui","year":"2021","journal-title":"Diagnostics (basel)"},{"issue":"1","key":"10.1016\/j.ctro.2025.100965_b0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-016-0715-6","article-title":"Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy","volume":"11","author":"Meng","year":"2016","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2025.100965_b0080","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1148\/rg.2021210037","article-title":"Radiomics in Oncology: A Practical Guide","volume":"41","author":"Shur","year":"2021","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.ctro.2025.100965_b0085","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1093\/oncolo\/oyac036","article-title":"Artificial Intelligencebased Radiomics in the Era of Immuno-oncology","volume":"27","author":"Kang","year":"2022","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.ctro.2025.100965_b0090","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/annonc\/mdx034","article-title":"Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology","volume":"28","author":"Limkin","year":"2017","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2025.100965_b0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.brachy.2023.06.004","article-title":"A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer","volume":"22","author":"Small","year":"2023","journal-title":"Brachytherapy"},{"issue":"10","key":"10.1016\/j.ctro.2025.100965_b0100","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.22.01096","article-title":"Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study","volume":"41","author":"Schmid","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.100965_b0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40644-022-00474-2","article-title":"MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy","volume":"22","author":"Zhang","year":"2022","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.ctro.2025.100965_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jrr\/rrab104","article-title":"Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multiinstitutional study of the Japanese Radiation Oncology Study Group","volume":"63","author":"Ikushima","year":"2022","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ctro.2025.100965_b0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2021.05.010","article-title":"IBSGEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer","volume":"160","author":"Mahantshetty","year":"2021","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2025.100965_b0120","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.brachy.2017.07.009","article-title":"Dosimetric analysis and preliminary clinical result of image-guided brachytherapy with or without hybrid technique for cervical cancer using VariSource titanium ring applicator with \u201cSiriraj Ring Cap\u201d","volume":"16","author":"Dankulchai","year":"2017","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.ctro.2025.100965_b0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/ijmr.IJMR_4183_20","article-title":"Para-aortic lymph node involvement in cervical cancer: Implications for staging, outcome and treatment","volume":"154","author":"Shylasree","year":"2021","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.ctro.2025.100965_bib126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5114\/jcb.2024.141458","article-title":"Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer","volume":"16","author":"Dankulchai","year":"2024","journal-title":"J Contemp Brachytherapy"}],"updated-by":[{"DOI":"10.1016\/j.ctro.2026.101128","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000}},{"DOI":"10.1016\/j.ctro.2026.101128","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T20:17:51Z","timestamp":1752783471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"alternative-id":["S2405630825000552"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100965","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100965"}}